Thanks, Kim. And good morning, everyone. I monitor to be Hillenbrand's next CFO. Hillenbrand has a great foundation, and I'm excited about the opportunities we have to drive significant organic and inorganic growth over the long term. More importantly, Hillenbrand has a great team and I've been impressed with the quality of talent and level of dedication on display throughout the organization. I'd like to thank Kim and the Hillenbrand board for their confidence in me. And I'd like to thank Kristina for her support during our transition. I look forward to continuing Hillenbrand's track record of transparency and shareholder engagement as I meet with many of you over the next weeks and months ahead. With that, just a reminder that throughout my section, I will be discussing our performance on a pro-forma basis, which has been adjusted for the divestitures of ABEL and TerraSource Global. We believe this provides a better assessment of our ongoing operations, and you will find a reconciliation of reported in pro-forma results in the appendix of the earnings slide deck. Turning to Slide 9, in our second quarter, we delivered revenue of $742 million, an increase of 5% or 8% excluding the impact to foreign currency. This growth was led by strong performance within our Advanced Process Solutions segment and the impact of pricing across all three operating segments. As Kim mentioned earlier, supply chain challenges, inflation, and foreign currency headwinds, escalated throughout the quarter. Our teams responded well in mitigating the rising costs, particularly in the areas of transportation and fuel. And we achieved price-cost coverage of approximately 90%, which was up from 65% in Q1, in line with our expectations. We continually evaluate additional pricing actions required to mitigate the increasing supply-chain costs. And we remain on track to achieve 100% price-cost coverage as we exit the fiscal year. We reported GAAP net income of $54 million or $0.74 per share. A decrease from a $1.3 per share in the prior year, primarily due to the prior year gain on the sale of able. Adjusted earnings per share of a $1.1 came in at the high end of our expectations and was up $0.03 or 3% compared to the prior year as favorable pricing, productivity improvements, and higher volume were partially offset by inflation, a higher tax rate, increased strategic investments, and the impact of foreign currency exchange. The adjusted effective tax rate in the quarter was 30.1%. An increase of 300 basis points over the prior year due to timing of discrete items. We still expect the full-year rate to be in the range of 28% to 30% as communicated last quarter. Adjusted EBITDA of $137 million increased 4% or 8% excluding foreign currency exchange. While adjusted EBITDA margin of 18.5% decreased 20 basis points primarily due to inflation and strategic investments. We had cash flow from operations of $46 million in the quarter, which was lower than the prior year, largely due to timing of working capital. We expect cash flow to be stronger in the second half of the fiscal year compared to the first half, and we're still targeting free cash flow conversion of approximately 100% for the full-year. Capital expenditures were $10 million, which was lower than expected, again this quarter due to continued delays from our capital equipment suppliers, which we anticipate will persist throughout the rest of the year. We now expect full-year CapEX to be approximately $50 million compared to the original estimate of $75 million. We continue to focus on high-return investments for our business, particularly in the areas of growth and innovation, as well as automation to improve overall efficiency. Our total backlog of $1.7 billion increased 14% compared to the prior year, with record backlog in MTS. Our backlog continues to provide us a strong foundation as we move forward with approximately 22% of the backlog scheduled to flow beyond the next 12 months. Moving to segment performance on Slide 10. We had strong revenue and margin expansion in the quarter for the APS segment. Revenue of $350 million increased 11% or 16%, excluding the impact of foreign currency driven by higher volume of large plastics systems, favorable pricing, and higher aftermarket parts, and service revenue. We were pleased to see yet another quarter of strong aftermarket orders, but supply chain delays and shortages continued to impact our ability to convert to revenue at normal rate. While we still expect full-year aftermarket revenue growth of mid-single-digits. This is lower than we originally expected. Adjusted EBITDA of $65 million increased 24% or 30% excluding the impact of foreign currency. While adjusted EBITDA margin of 20.7% increased 210 basis points from the prior year. As favorable pricing, operating leverage from higher volume and productivity improvements more than offset inflation and higher strategic investments. Price-cost coverage for ATFs was approximately 95% in the quarter. But based on additional pricing actions, we're taking, we accept, we're back to a 100% in the second half. However, as a reminder, unit of 100% price-cost coverage, we will see a diluted impact to margins. Order backlog of $1.3 billion increased 13% year-over-year, or 17% excluding the impact of foreign currency, primarily driven by large plastics systems and aftermarket parts and services. The pipeline for large plastics projects remains healthy with continued solid demand in China. We're also seeing year-over-year and sequential increases in the coal pipeline for India and the Middle East. We continue to be encouraged by the opportunities we see across the strategic end markets for food, recycling, biopolymers and battery. While these end markets are relatively small portions of our business today, we believe our efforts in developing innovative products and solutions for our customers and forging strategic partnerships will position us well for the future in serving these areas. Turning to Molding Technology Solutions on Slide 11. Revenue of $251 million decreased 2% compared to the prior year, but was flat excluding the impact of foreign currency, as favorable pricing and higher volume in our hot runner product line was offset by a decline in volume in our injection molding and extrusion product lines. Adjusted EBITDA of $50 million decreased 1% while adjusted EBITDA margin of 20.1% increased 10 basis points as favorable pricing and productivity improvements were mostly offset by inflation. Price-cost coverage for the quarter was approximately 95%, which was in line with our expectations. We continue to see opportunity to expand margins in the segment over the next several years, particularly within the injection molding product line through the deployment of the Hillenbrand operating model. Order volumes continue to be solid for both hot runners and injection molding. But we're down from last year, where we experienced pent-up demand for injection molding equipment. Record order backlog of $418 million was up 15% compared to the prior year, and 3% sequentially. With that being said, we continue to see supply chain and labor constraints effect our ability to convert orders to revenue as quickly as we would have in a normalized environment. Turning to Batesville on Slide 12. Batesville performance performed above our expectations given the unfortunate circumstances related to the Omicron variant. Compared to the prior year revenue of $176 million increased 6% due to higher average selling price, primarily due to the price surcharge implemented in January to offset significant increase in commodity costs. Burial volume was lower than the prior year, primarily due to an estimated increase at which families opted for cremation. While we continue to monitor the latest trends, we expect dust to return to pre -pandemic trends as we progress through the second half of fiscal year 2022. And as Kim mentioned, we have already begun to see the state place to the start of the third quarter. Adjusted EBITDA of $37 million decreased 17% and adjusted EBITDA margin of 21.1% decreased 580 basis points as inflation and the impact of lower volume outweighed our pricing actions and productivity improvements. As a reminder, the price surcharge has a dilutive impact to margins since it is fully offset by inflation on a dollar-for-dollar basis. Price-cost coverage was approximately 80% in the quarter, which was lower than we expected due to continued rise in commodity and transportation costs. In response to the continued inflationary pressure, we are implementing an additional commodity price surcharge to help mitigate the impact. Now, turning to the balance sheet on Slide 13. Net debt at the end of the second quarter was $769 million with a net debt-to-adjusted EBITDA ratio of 1.4, which was essentially flat on a sequential basis. As of quarter end, we have liquidity of approximately $1.3 billion, including $445 million of cash on hand and the remainder under our revolving credit facility. As of March 31st, we had no borrowings on our revolver and no near-term debt maturities. Given the strength of our balance sheet, I am confident in our ability to manage through the uncertain operating environment and continue to drive profitable growth strategy to deliver long-term shareholder value. Moving to capital deployment on Slide 15, we've returned approximately $43 million to shareholders during the quarter through the purchase of approximately 580,000 shares for $27 million and 16 million through our quarterly dividend. During the third quarter, we have repurchased approximately 930,000 shares for $41 million, and we have approximately $233 million remaining under our authorization. We continue to maintain our disciplined approach to capital allocation with a focus on maximizing long-term shareholder returns. Our top priority for capital continues to be strategic investments to drive profitable growth in our industrial products platforms, including strategic bolt-on M&A opportunities that we expect will accelerate our growth and provide appropriate returns. We will also continue to consider opportunistic share repurchases. Turning to Slide 15. I will conclude my prepared remarks with an update on our outlook for the third-quarter and full-year. As a reminder, our guidance is on a pro-forma basis, which is adjusted for the divestitures of Red Valve, ABEL and TerraSource. As the basis for our outlook, we expect supply chain disruptions, inflation, labor market shortages and foreign currency to remain a headwind through the rest of the year. I'd like to highlight that we're continually monitoring the evolution in China and continued impact from the war in Ukraine. Our guidance assumes China capacity normalizes as we entered June. However, a worsening of the macro-environment, including additional or prolonged shutdowns in China, or a further escalation of supply-chain issues for inflationary pressures will have an adverse effect on our targeted performance. We are raising our estimate for the full-year consolidated revenue to be $2.9 billion to $2.98 billion a year-over-year increase of four to 6% compared to our previous estimate of up 3% to 6%. We are maintaining our expectation for full year adjusted earnings per share to be in a range of $3.80 to $4. For ATFs, we are maintaining our full year revenue expectation as lower ability to convert aftermarket orders and additional foreign currency pressure is being offset by continued strength in large plastics systems and additional pricing. We are updating our full year margin outlook to be in the range of 20% to 21%, which still reflects year-over-year expansion of 50 to 150 basis points. But as lower than our previous guidance, primarily due to the dilutive effect of price cost and unfavorable portfolio mix. For MTFs, we are maintaining our full year revenue and margin expectations. While we expect a shortfall and hot runner revenue in Q3 due to the shutdowns in China, we currently expect recover the shortfall within the fiscal year. Now, turning to Batesville. We expect revenue to be the range of $605 million to $615 million, down 1% to 3% versus the prior year compared to our previous expectation of down five to 6% This change as a result of higher-than-expected volume in our second quarter and additional surcharge pricing in the second half of the fiscal year. We are maintaining our expectation for Batesville margin to be a range of 20 to 21% for the full-year. Finally, for our third quarter, we expect the COVID-related shutdowns in China to negatively impact performance, primarily within our hot runner product line, but we've already seen roughly $10 million of top-line impact in April. The situation has modestly improved so far in May, and our current guidance assumes further normalization as we entered June. We currently expect to recover the shortfall in our fourth-quarter. We expect our Q3 adjusted earnings per share to be in the range of $0.83 to $0.90 down sequentially, primarily due to lower Batesville volume, the impact from China, and further krone currency pressure. Batesville margin and revenue will be down a sequential basis due to significantly lower volume as a result of lower COVID deaths, a normal seasonality of base [Indiscernible], in addition to the dilutive impact of price cost. We expect APS to be roughly flat on a sequential basis for both revenue and margin. Lastly, we expect MTS to be modestly higher on revenue, but modestly lower on margin compared to Q2 due to higher relative mix of injection molding equipment. Please review Slide 15 of the earnings presentation for additional guidance assumptions. And now I'll turn the call back over to Kim.